17-39972607-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_178171.5(GSDMA):c.724G>T(p.Val242Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000664 in 1,612,630 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_178171.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSDMA | NM_178171.5 | c.724G>T | p.Val242Phe | missense_variant | 7/12 | ENST00000301659.9 | NP_835465.2 | |
GSDMA | XM_006721832.4 | c.724G>T | p.Val242Phe | missense_variant | 7/12 | XP_006721895.1 | ||
GSDMA | XM_011524651.4 | c.298G>T | p.Val100Phe | missense_variant | 5/10 | XP_011522953.1 | ||
GSDMA | XM_017024502.3 | c.703+431G>T | intron_variant | XP_016879991.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSDMA | ENST00000301659.9 | c.724G>T | p.Val242Phe | missense_variant | 7/12 | 1 | NM_178171.5 | ENSP00000301659.4 | ||
GSDMA | ENST00000635792.1 | c.724G>T | p.Val242Phe | missense_variant | 7/12 | 5 | ENSP00000490739.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000850 AC: 21AN: 246988Hom.: 0 AF XY: 0.0000971 AC XY: 13AN XY: 133816
GnomAD4 exome AF: 0.0000589 AC: 86AN: 1460300Hom.: 1 Cov.: 31 AF XY: 0.0000606 AC XY: 44AN XY: 726250
GnomAD4 genome AF: 0.000138 AC: 21AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at